Efficacy and Adverse Effects of Niraparib in Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
- Status
- RECRUITING
- Phase
- N/A
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1
Doxil/Caelyx BE Study
- Status
- COMPLETED
- Phase
- PHASE1
Role of Laparoscopy in Assessing Resectability of Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
- Status
- RECRUITING
- Phase
- PHASE2
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
- Status
- COMPLETED
- Phase
- NA
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Guangzhou Women's Health Cohort Study (GWHCS)
- Status
- SUSPENDED
- Phase
- N/A
Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay.
- Status
- COMPLETED
- Phase
- N/A
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Ovarian Cancer Individualized Scoring System Scoring System
- Status
- UNKNOWN
- Phase
- N/A
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Role of the ATP7A Transporter in Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2